Ident. | Authors (with country if any) | Title |
---|
001158 (2018) |
Masashi Narazaki [Japon] ; Tadamitsu Kishimoto [Japon] | The Two-Faced Cytokine IL-6 in Host Defense and Diseases. |
001325 (2018) |
Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Tadamitsu Kishimoto [Japon] | Interleukin (IL-6) Immunotherapy. |
001624 (2017) |
Masashi Narazaki [Japon] ; Toshio Tanaka [Japon] ; Tadamitsu Kishimoto [Japon] | The role and therapeutic targeting of IL-6 in rheumatoid arthritis. |
001B49 (2016) |
Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Tadamitsu Kishimoto [Japon] | Immunotherapeutic implications of IL-6 blockade for cytokine storm. |
002026 (2015) |
Yoshihito Shima [Japon] ; Naoki Hosen ; Toru Hirano ; Junsuke Arimitsu ; Sumiyuki Nishida ; Keisuke Hagihara ; Masashi Narazaki ; Atsushi Ogata ; Toshio Tanaka ; Tadamitsu Kishimoto ; Atsushi Kumanogoh | Expansion of range of joint motion following treatment of systemic sclerosis with tocilizumab. |
002423 (2014) |
Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Tadamitsu Kishimoto [Japon] | IL-6 in inflammation, immunity, and disease. |
002527 (2014) |
Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Tadamitsu Kishimoto [Japon] | A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy. |
003454 (2012) |
Toshio Tanaka [Japon] ; Masashi Narazaki ; Tadamitsu Kishimoto | Therapeutic targeting of the interleukin-6 receptor. |
003574 (2012) |
Toru Hirano [Japon] ; Nobuyuki Ohguro ; Satoshi Hohki ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Atsushi Ogata ; Kazuyuki Yoshizaki ; Atsushi Kumanogoh ; Tadamitsu Kishimoto ; Toshio Tanaka | A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab. |
003844 (2012) |
Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Tadamitsu Kishimoto [Japon] | Therapeutic Targeting of the Interleukin-6 Receptor |
003912 (2011) |
Masashi Narazaki ; Keisuke Hagihara ; Yoshihito Shima ; Atsushi Ogata ; Tadamitsu Kishimoto ; Toshio Tanaka | Therapeutic effect of tocilizumab on two patients with polymyositis. |
003924 (2011) |
Sumiyuki Nishida [Japon] ; Tomio Kawasaki ; Hirokazu Kashiwagi ; Atsuyoshi Morishima ; Yoshihiro Hishitani ; Mari Kawai ; Toru Hirano ; Taeko Ishii ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Atsushi Ogata ; Yoshihiro Oka ; Tadamitsu Kishimoto ; Toshio Tanaka | Successful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab. |
003A06 (2011) |
Toshio Tanaka [Japon] ; Masashi Narazaki ; Tadamitsu Kishimoto | Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases. |
003A44 (2011) |
Atsushi Ogata [Japon] ; Atsuyoshi Morishima [Japon] ; Toru Hirano [Japon] ; Yoshihiro Hishitani [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Toshio Tanaka [Japon] | Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab |
003A77 (2011) |
Toshio Tanaka [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Atsushi Kumanogoh [Japon] | Tocilizumab, a humanized anti‐interleukin‐6 receptor antibody, for the treatment of autoimmune disorders |
003C13 (2011) |
Masashi Narazaki [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Atsushi Ogata [Japon] ; Tadamitsu Kishimoto [Japon] ; Toshio Tanaka [Japon] | Therapeutic effect of tocilizumab on two patients with polymyositis |
003C35 (2011) |
Atsushi Ogata [Japon] ; Atsuyoshi Morishima [Japon] ; Toru Hirano [Japon] ; Yoshihiro Hishitani [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Toshio Tanaka [Japon] | Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab |
003C70 (2010) |
Toshio Tanaka [Japon] ; Atsushi Ogata ; Masashi Narazaki | Tocilizumab for the treatment of rheumatoid arthritis. |
003C97 (2010) |
Atsushi Ogata [Japon] ; Masahide Mori ; Shoji Hashimoto ; Yukihiro Yano ; Takeya Fujikawa ; Mari Kawai ; Yusuke Kuwahara ; Toru Hirano ; Junsuke Arimitsu ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Souichirou Yokota ; Tadamitsu Kishimoto ; Ichiro Kawase ; Toshio Tanaka | Minimal influence of tocilizumab on IFN-gamma synthesis by tuberculosis antigens. |
003D47 (2010) |
Yoshihito Shima [Japon] ; Yusuke Kuwahara [Japon] ; Hiroyuki Murota [Japon] ; Shun Kitaba [Japon] ; Mari Kawai [Japon] ; Toru Hirano [Japon] ; Junsuke Arimitsu [Japon] ; Masashi Narazaki [Japon] ; Keisuke Hagihara [Japon] ; Atsushi Ogata [Japon] ; Ichiro Katayama [Japon] ; Ichiro Kawase [Japon] ; Tadamitsu Kishimoto [Japon] ; Toshio Tanaka [Japon] | The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab |
003F20 (2010) |
Toshio Tanaka [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Ichiro Kawase [Japon] ; Tadamitsu Kishimoto [Japon] | Treatment of a patient with remitting seronegative, symmetrical synovitis with pitting oedema with a humanized anti-interleukin-6 receptor antibody, tocilizumab |